Cancer is rarely the result of a single pathway alteration. More often, it involves a complex network of pathways interacting in a highly regulated manner. Crosstalk between pathways such as PI3K/AKT/mTOR and RAS/RAF/MEK/ERK can amplify oncogenic signals, leading to enhanced cell proliferation and survival. Additionally, feedback loops and regulatory mechanisms are often disrupted, further contributing to cancer progression.
